YTHDC2 and metabolic dysfunction-associated steatotic liver disease: Zhou et al. found that the expression of YTHDC2 was significantly reduced in the liver of obese mice and non-alcoholic fatty liver disease (NAFLD) patients, and was associated with liver fat accumulation.